CannaInvestor Magazine Editor-in-Chief Louis Kyron joins James West in the Midas Letter studio to talk about the Canadian Medical Association’s recent declaration that it expects “the existing medical use framework to be dismantled, phased out, once legalization stats on October 17.” The pair address the impact on patients transitioning from medical teams, licensed producers, and special strains, to relying on retailers for information and guidance. Kyron discusses the growing body of research supporting cannabis as an alternative treatment to opiates. They examine cannabis taxation and what that means for the black market. The segment concludes with a discussion of cannabis brewing companies to watch.
CannaInvestor Magazine discusses Cannabis beverage Companies with Midas Letter
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.